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Ticks are obligate hematophagous ectoparasites that transmit a wide variety of pathogens
to humans and animals. The incidence of tick-borne diseases has increased worldwide
in both humans and domestic animals over the past years resulting in greater interest in
the study of tick-host-pathogen interactions. Advances in vector and pathogen genomics
and proteomics have moved forward our knowledge of the vector-pathogen interactions
that take place during the colonization and transmission of arthropod-borne microbes.
Tick-borne pathogens adapt from the vector to the mammalian host by differential gene
expression thus modulating host processes. In recent years, studies have shown that
targeting tick proteins by vaccination can not only reduce tick feeding and reproduction,
but also the infection and transmission of pathogens from the tick to the vertebrate host.
In this article, we review the tick-protective antigens that have been identified for the
formulation of tick vaccines and the effect of these vaccines on the control of tick-borne
pathogens.
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INTRODUCTION
Ticks are of great medical and veterinary importance as they
can transmit a wide variety of infectious agents (de la Fuente
et al., 2008a). The family Ixodidae comprises hard ticks of
the Amblyomma, Dermacentor, Rhipicephalus, and Ixodes spp.
that not only inflict direct damage to their host but also rank
second to mosquitoes as vectors of disease. The Ixodes rici-
nus species alone transmits viruses, bacteria, and protozoa that
cause in humans tick-borne encephalitis, Lyme disease, and
babesiosis, respectively (de la Fuente et al., 2008a). In cat-
tle, anaplasmosis caused by Anaplasma spp., and babesiosis,
caused by Babesia spp., are two of the most important dis-
eases transmitted by Rhipicephalus spp. ticks (Merino et al.,
2011a).
Vector-borne diseases are on the increase and new infec-
tious agents are also emerging leading to significant public
health concerns as potential zoonotic disease threats (Parola and
Raoult, 2001; de la Fuente and Estrada-Peña, 2012). Amongst
other factors, climate change itself can have an adverse effect
on the distribution of ticks and tick-borne diseases. It is
predicted that more than 50% of tick species of the genus
Rhipicephalus (Boophilus) could expand its range in Africa, with
more than 70% of this range expansion linked to economically
important tick species such as R. appendiculatus, R. microplus,
or R. decoloratus (Estrada-Peña et al., 2006; Olwoch et al.,
2007).
The ultimate goal of arthropod vector vaccines is the control of
vector infestations and vector-borne diseases (VBD). The effect of
vector vaccines on VBD could be obtained by (a) reducing vector
populations and thus the exposure of susceptible hosts to vector-
borne pathogens, (b) reducing the arthropod vector capacity for
pathogen transmission, and, preferably, (c) a combination of
these factors.
Herein, we review recent advances in tick vaccine develop-
ment focused on discovery and characterization of tick protective
antigens that impact on pathogen infection and transmission.
Identification of molecules essential for both tick survival and
pathogen infection and transmission will likely contribute to the
discovery of novel vaccine strategies for the simultaneous control
of ticks and tick-borne pathogens (Figure 1).
CONTROL METHODS FOR TICKS AND TICK-BORNE
DISEASES
A major component of integrated tick control has been the appli-
cation of acaricides. However, their use has had limited efficacy
in reducing tick infestations and is often accompanied by seri-
ous drawbacks, including the selection of acaricide-resistant ticks,
environmental contamination and contamination of milk and
meat products with drug residues (Graf et al., 2004; Ghosh et al.,
2007).
An alternative host-targeted method involves the elimination
of ticks from the host using baits impregnated with different com-
pounds such as acaricides or antibiotics. Immature I. scapularis
ticks were eliminated from mice using bait boxes impregnated
with fipronil, therefore reducing the subsequent populations
of nymphs and adults and thus reducing the proportion of
ticks infected with the Lyme disease agent, Borrelia burgdorferi
(Sonenshine et al., 2006). Field trials by Dolan et al. (2011)
have revealed that infections rates with A. phagocytophilum and
B. burgdorferi can be significantly reduced in both rodent reser-
voirs and ticks I. scapularis using antibiotic-treated baits. Thus
this method can successfully reduce tick infestations and may also
help to reduce pathogen transmission but can also contribute to
the selection of acaricide and/or antibiotic resistant ticks.
Ecological approaches to control diseases involve intervention
in the natural cycle of disease agents vaccinating wild reservoirs
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FIGURE 1 | Transmission blocking vaccines based on tick recombinant
proteins aim to reduce vector infestations and the infection and
transmission of vector-borne pathogens (VBP).
but the effects may be complex and hard to predict. For instance,
Tsao et al. (2004) immunized white-footed mice, reservoir host
for the Lyme disease agent, with a recombinant outer surface pro-
tein A (OspA). Even though vaccination significantly reduced the
prevalence of B. burgdorferi in nymphal ticks, the results also indi-
cated that non-mouse hosts played a larger than expected role in
infection dynamics, suggesting the need to vaccinate additional
hosts.
Entomopathogenic fungi, such as Metarhizium anisopliae and
Beauveria bassiana, are active against a range of several eco-
nomically important species of ticks under laboratory and field
conditions, for example R. annulatus (Pirali-Kheirabadi et al.,
2007), I. scapularis (Hornbostel et al., 2005), R. appendiculatus
and A. variegatum (Kaaya et al., 1996). Despite the relative safety
of this type of biocontrol method they haven’t been successfully
implemented as yet because of their environmental instability,
and potential damage to non-target species.
Ticks can harbor a wide range of endosymbiotic bacte-
ria including Rickettsia, Francisella, Coxiella, and Arsenophonus,
amongst others (Alberdi et al., 2012). Tick control strategies could
be devised based on interference with their endosymbionts for
the control of these vectors and the pathogens they hold (Ghosh
et al., 2007). For instance, Wolbachia pipientis when transfected
into Aedes aegypti mosquitoes hinders the replication of Dengue
and Chikungunya viruses (Iturbe-Ormaetxe et al., 2011).
Vaccination is an attractive alternative for the control of
tick infestations and pathogen infections as it is a more
environmentally friendly method. By targeting a common vec-
tor, several tick-borne diseases can be controlled simultane-
ously (Brossard, 1998; de la Fuente et al., 1998, 2007a,b, 2011;
Rodríguez Valle et al., 2004; Almazán et al., 2005b). Since vector-
borne pathogens exploit tick proteins to establish an infection,
targeting the pathogen in the vector by blocking transmission
is an innovative and promising method to control vector-borne
infections (Lee and Opdebeeck, 1999; Havlíková et al., 2009).
However, the selection of suitable antigens is a major constraint
on vaccine development.
FINDING CANDIDATE TICK PROTECTIVE ANTIGENS
Candidate tick protective antigens have been identified using
high throughput screening technologies allowing rapid, system-
atic and global antigen screening and providing a comprehen-
sive approach for the selection of candidate vaccine antigens
(Diatchenko et al., 1999; Almazán et al., 2003; Antunes et al.,
2012). Other screening approaches include using RNA interfer-
ence (RNAi) (de la Fuente et al., 2005, 2008b, 2010; Almazán et al.,
2010; Kocan et al., 2011) and capillary feeding (Almazán et al.,
2005a; Canales et al., 2009a; Gonsioroski et al., 2012; Rodriguez-
Valle et al., 2012). Using a functional genomics approach, Antunes
et al. (2012) identified differentially expressed genes in B. bigem-
ina-infected Riphicephalus ticks. TROSPA and serum amyloid A
in particular significantly reduced bacterial infection levels in the
ticks. Other methods such as protein arrays (Manzano-Román
et al., 2012) and yeast surface display (Schuijt et al., 2011b) have
also been proposed for the identification and characterization of
antigens that elicit tick immunity.
The tick protective antigen, Subolesin, was discovered by
expression library immunization and evaluation of expressed
sequence tags (Almazán et al., 2003). Ghosh et al. (2008)
employed strategic methods for the isolation of targeted
molecules using affinity purification of proteins showing reac-
tivity with immunoglobulins of animals previously immunized
with different sources of tick antigens. Rachinsky et al. (2008)
investigated the differences in protein expression in midgut tis-
sue of uninfected and Babesia bovis-infected R. microplus ticks
to establish a proteome database containing proteins involved in
pathogen transmission. As pathogen neutralization occurs within
the feeding vector, the development of a successful transmission-
blocking vaccine requires that the antigen induce high and
long-lasting circulating antibody titers in immunized hosts.
Nano/microparticle technologies can be applied toward the
development of transmission-blocking vaccines that target anti-
gens expressed only inside the vector. Although not yet used in
ticks, experiments by Dinglasan et al. (2013) showed that a single
inoculation and controlled release of mosquito antigen in mice,
elicited long-lasting protective antibody titers against malaria sex-
ual stages. Conserved carbohydrate targets have been identified
in the midgut of arthropod species (Dinglasan et al., 2005) and
are a promising tool for the elaboration of transmission blocking
vaccines that control a wide range of arthropod vectors.
SPECIFIC TICK ANTIGENS AND THEIR EFFECT ON
PATHOGEN TRANSMISSION (SEE TABLE 1)
BM86-BASED VACCINES
Tick vaccines became commercially available in the early 1990’s
for the control of cattle tick infestations (Willadsen et al., 1995;
Canales et al., 1997; de la Fuente et al., 1998, 2007b). TickGARD
(in Australia) and Gavac (in Latin American countries) are both
derived from R. microplus midgut membrane-bound recom-
binant protein BM86. The protective action of BM86-based
vaccines in cattle is due to the positive correlation between
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Table 1 | Overview of tick protective antigens and their effect on the control of tick-borne pathogens.
Vaccinated hosts (N)a Recombinant
tick antigen
Vectorb Pathogenc Reduction in vector
infectiond
References
Cattle (>260,000) Bm86 R. microplus Babesia sp. 76%e de la Fuente et al., 1998
Cattle (>260,000) Bm86 R. microplus Anaplasma sp. No effect de la Fuente et al., 1998
Cattle (5) Ba86 R. annulatus Babesia sp. N/D Canales et al., 2009a
Cattle (5) Ba86 R. annulatus Anaplasma sp. N/D Canales et al., 2009a
Rabbit (4) Bm95 R. microplus Babesia sp. N/D Canales et al., 2009b
Rabbit (4) Bm95 R. microplus Anaplasma sp. N/D Canales et al., 2009b
Cattle (5) HGAg H. a. anatolicum Theileria annulata 10% Das et al., 2005; Ghosh
et al., 2008;
Cattle (5) Haa86 H. a. anatolicum Theileria annulata 3 calves survived
lethal challenge
Jeyabal et al., 2010
Cattle (5) Bm91 R. microplus Babesia, N/D Willadsen et al., 1996
Cattle (5) Bm91 R. microplus Anaplasma N/D Willadsen et al., 1996
Mice (5) SUB I. scapularis A. phagocytophilum 33% de la Fuente et al., 2006b
Cattle (4) SUB R. microplus A. marginale 98% Merino et al., 2011b
Cattle (4) SUB R. microplus B. bigemina 99% Merino et al., 2011b
Mice (15) SUB I. scapularis B. burgdorferi 40% Bensaci et al., 2012
Mice (10) 64TPR I. ricinus TBEV 52% Labuda et al., 2006





N/D Hajdusek et al., 2010
Mice (5) Salp15 I. scapularis B. burgdorferi 60% Dai et al., 2009
Mice (5) Salp25D I. scapularis B. burgdorferi Three-fold Narasimhan et al., 2007
Cattle (5) RAS-3, RAS-4,
RIM36 coktail
R. appendiculatus T. parva 38% Imamura et al., 2008
Mice (5) TROSPA I. scapularis B. burgdorferi 75% Pal et al., 2004
Mice (5) tHRF I. scapularis B. burgdorferi 20–30% mice fully
protected
Dai et al., 2010
Mice (3) TSLPI I. scapularis B. burgdorferi 30% Schuijt et al., 2011a
aN, number of individuals per group.
bArthropod vector species in which vaccine was tested.
cPathogen species in which the effect of vaccination was tested.
d Reduction in vector infection was determined with respect to the control group vaccinated with adjuvant/saline.
eOverall reduction in the incidence of dead animals caused by infections with Babesia sp. after vaccination.
Abbreviation: N/D, not determined.
antigen-specific antibodies and reduction of ticks infestations and
fertility (Rodríguez et al., 1995; de la Fuente et al., 1998; Merino
et al., 2011a). The mechanism by which BM86 immunization
affects ticks involves antibody-antigen interaction that interferes
with the still unknown BM86 biological function thus reduc-
ing the number, weight and reproductive capacity of engorging
female ticks (de la Fuente et al., 1998, 1999). As a result, the preva-
lence of some tick-borne pathogens can indirectly be affected (de
la Fuente et al., 2007b). Vaccine trials with BM86 resulted in a
reduction in the incidence of babesiosis, as well as reduced tick
infestations in vaccinated cattle herds, and these results were cor-
roborated in extensive field trials (de la Fuente et al., 1998, 2007a;
Rodríguez Valle et al., 2004). However, because A. marginale
is also mechanically transmitted by blood-contaminated mouth
parts of biting insects and fomites, BM86 antigen vaccination
controlled the transmission of A. marginale only in regions where
ticks are the main vectors (de la Fuente et al., 1998).
Despite the effectiveness of these commercial BM86-based vac-
cines for the control of cattle tick infestations, they show strain-to
strain variation in efficacy and are effective against Rhipicephalus
tick species mainly (de la Fuente and Kocan, 2003; Willadsen,
2006; de la Fuente et al., 2007a,b; Odongo et al., 2007) hence the
need to develop improved vaccine formulations (Guerrero et al.,
2012).
BM86 ORTHOLOGS AND HOMOLOGS
BA86 is a recombinant R. annulatus BM86 ortholog protein
with over 90% similarity to BM86 (Canales et al., 2008).
Experimental trials in cattle proved the efficacy of recombi-
nant BA86 for the control of R. annulatus and R. microplus
infestations, showing that the efficacy of both BM86 and BA86
is higher against R. annulatus. These results suggested that
physiological differences between R. microplus and R. annu-
latus and those encoded in the sequence of BM86 orthologs
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may be responsible for the differences in susceptibility of tick
species to BM86 vaccines (Canales et al., 2009a; Jeyabal et al.,
2010).
A BM86 ortholog of Hyalomma anatolicum anatolicum,
HAA86, was cloned and expressed by Azhahianambi et al. (2009).
Jeyabal et al. (2010) reported that vaccination of cattle with
the recombinant HAA86 antigen did not only protect against
homologous tick challenge but also reduced tick transmission
of Theileria annulata, thus protecting the animals against lethal
exposure.
The R. microplus BM95 glycoprotein is a BM86 homologue
that protects cattle against infestations by South American cat-
tle tick strains not protected by BM86 vaccination (Canales et al.,
2009b). Studies with BM95 have shown it protects against a
broader range of tick strain infestations suggesting BM95 could
be a more universal antigen against infestations by R. microplus
strains from different geographical areas (García-García et al.,
2000; de la Fuente and Kocan, 2003).
The number of new upcoming promising targets that can
affect both tick infestations and pathogen transmission is rising.
Nijhof et al. (2010) have recently identified a novel protein from
metastriate ticks with structural similarities to BM86, named
ATAQ after a part of its signature peptide. Although its function
is unknown, ATAQ is expressed in both midguts and Malpighian
tubules, while BM86 is expressed only in midguts. The vaccine
efficacy of recombinant ATAQ proteins against tick infestations
has not been evaluated but it may constitute a good vaccine candi-
date with an increased cross-protective effect against heterologous
ticks compared to BM86-based vaccines because ATAQ proteins
are more conserved.
TICK SALIVARY PROTEINS
Arthropod vectors induce immunosuppression in the host dur-
ing feeding and secrete pathogen transmission-enhancing factors
that counteract host rejection responses. For example, the Lyme
disease agent B. burgdorferi exploits tick salivary proteins (B-cell
inhibitory protein BIP and Salp15 from I. ricinus and I. scapularis,
respectively) to facilitate transmission to the mammalian host
(Anguita et al., 2002, 2003; Hannier et al., 2004; Ramamoorthi
et al., 2005). During feeding, tick salivary glands secrete a large
variety of pharmacologically active molecules with immunosup-
presive properties that facilitate pathogen transmission and are
potential candidates for anti-tick vaccines that limit infestations
and interfere with tick-borne pathogen transmission (Valenzuela,
2002; Ribeiro and Francischetti, 2003; Nuttall et al., 2006; Titus
et al., 2006; Nuttall, 2009).
64TRP is a 15 kDa protein that resembles mammalian host
skin proteins, identified in expression libraries as a putative
tick cement protein involved in the attachment and feeding
of R. appendiculatus (Trimnell et al., 2002; Havlíková et al.,
2009). The protein derives from the cement cone that secures
the tick’s mouthparts in the host skin and, as a broad-spectrum
vaccine antigen, is effective against adult and immature stages
of several tick species, including I. ricinus (Trimnell et al.,
2005). Recombinant forms of R. appendiculatus 64TRP induce
potent humoral and delayed type hypersensitivity responses
(Trimnell et al., 2002). In hamster, guinea pig and rabbit models
this cement antigen acts as a dual-action vaccine by target-
ing the tick-feeding site (impairing attachment and feeding)
and cross-reacting with “concealed” midgut antigens, result-
ing in death of engorged ticks (Trimnell et al., 2002, 2005;
Havlíková et al., 2009). Histological and immunocytological
studies have indicated that the key mode of action of 64TRP
immunisation is the local cutaneous delayed type hypersensi-
tivity response induced at the skin site of tick feeding (Labuda
et al., 2006). Recent experiments have illustrated how vaccina-
tion with this antigen also affects tick vector capacity. Labuda
et al. (2006) reported that vaccination of mice with 64TRPP
antigen prevented transmission of tick-borne encephalitis virus
(TBEV) by I. ricinus thus having a protective effect on pathogen
transmission.
Salp15 is another secreted salivary protein with host
immunosuppressive properties, inhibiting CD4+ T-cell activation
(Anguita et al., 2002), complement activity (Schuijt et al., 2008),
and dendritic cell function (Hovius et al., 2008a). OspC is an
outer surface protein produced by B. burgdorferi. When ticks take
a blood meal, the spirochetes initiate its synthesis in the midguts
of infected ticks. Salp15 physically binds to OspC on B. burgdor-
feri spirochetes surface during exit from the salivary glands,
facilitating the survival of spirochetes, pathogen transmission
and host infection (Ramamoorthi et al., 2005; Dai et al., 2009).
Salp15-OspC interaction potentially conceals OspC from the
host immune response protecting the spirochete (Ramamoorthi
et al., 2005). Mice immunized with recombinant Salp15 and chal-
lenged with B. burgdorferi infected nymphs were significantly
protected from infection (Dai et al., 2009). Antibodies directed
against Salp15 may separate Salp15 away from OspC leaving
it exposed to the immune responses, or, hypothetically, Salp15
antibodies could bind to Salp15-coated spirochetes and release
the spirochetes more effectively to phagocytes (Dai et al., 2009).
Immunization of murine hosts with a combination of Salp15
and OspA provide better protection from B. burgdorferi infec-
tion than either alone (Dai et al., 2009). Salp15 homologs have
been identified in I. ricinus ticks, they also bind B. garinii and B.
afzelii OspC to facilitate spirochete transmission (Hovius et al.,
2008b).
Salp25D is expressed by I. scapularis salivary glands and
midguts (Das et al., 2001) and has homology to peroxiredox-
ins antioxidants (Barr and Gedamu, 2003). Immunization of
mice with rSalp25D reduces Borrelia acquisition by I. scapu-
laris (Narasimhan et al., 2007) demonstrating it plays a criti-
cal role during tick feeding in the mammalian host, protecting
the bacteria from reactive oxygen produced by neutrophils and
facilitating Borrelia acquisition by ticks. Therefore it could be
used to vaccinate reservoir hosts to interrupt the spirochete
life cycle and reduce its prevalence in ticks in Lyme disease
endemic areas. Interestingly, Salp25D does not influence trans-
mission from the tick to the mammalian host (Narasimhan et al.,
2007).
The tick histamine release factor (tHRF) from I. scapularis
was characterized by Dai et al. (2010). tHRF is secreted in tick
saliva, upregulated in B. burgdorferi-infected ticks and it appears
to have a role in tick engorgement and efficient B. burgdor-
feri transmission (Dai et al., 2010). Silencing tHRF by RNAi
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significantly impaired tick feeding and decreased B. burgdorferi
infection levels in mice. Actively immunized mice with recom-
binant tHRF, or passively transferring tHRF antiserum, also
markedly reduced the efficiency of tick feeding and B. burgdorferi
infection in mice. Blocking tHRF might offer a viable strat-
egy to develop vaccines that block tick feeding and therefore
transmission of tick-borne pathogens.
The I. scapularis salivary protein TSLPI (Tick Salivary Lectin
Pathway Inhibitor) identified by Schuijt et al. (2011a) protects
B. burgdorferi from direct killing by the host complement sys-
tem. Silencing TSLPI mRNA significantly reduces Borrelia loads
in nymphs and also impairs transmission to mice. TSLPI plays a
significant role in both transmission and acquisition of Borrelia
(Schuijt et al., 2011a) but immunization against rTSLPI does not
completely block bacterial transmission from the tick to the host,
suggesting the need for a combination of tick proteins in future
tick antigen-based vaccines to prevent Lyme disease (Schuijt et al.,
2011b).
OTHER TICK PROTEINS
Ferritins are iron-storage proteins that play a pivotal role in
the homeostasis of iron during tick feeding. A common heavy
chain type ferritin 2 (Kopacek et al., 2003), without functional
orthologs in vertebrates, has been recently characterized as a
gut-specific protein secreted into the tick hemolymph, where it
acts as an iron transporter (Hajdusek et al., 2009). Ferritin 2
(RmFER2) knockdown by RNAi and vaccination with the recom-
binant protein resulted in reduction of feeding, oviposition and
fertility in I. ricinus, R. microplus and R. annulatus (Hajdusek
et al., 2009, 2010) thus highlighting its potential use as a future
dual action tick and tick-borne diseases protective antigen candi-
date.
TROSPA is a tick receptor for B. burgdorferi OspA that has
been identified in the tick midgut (Pal et al., 2004; Antunes
et al., 2012). Tick-borne pathogens can adapt from the vector to
the mammalian host by differential gene expression. For exam-
ple, outer surface proteins OspA and OspB are produced when
Lyme disease spirochetes enter and reside in ticks (Pal and Fikrig,
2003) but they are downregulated during transmission to the
host. Other genes that facilitate transmission from ticks and col-
onization of the host such as bba52 and OspC are upregulated.
TROSPA expression is upregulated during B. burgdorferi infec-
tion and downregulated during tick engorgement. The recep-
tor’s physiological function is unknown but binding of OspA
to TROSPA is essential for B. burgdorferi to colonize the tick
gut, thus supporting bacterial infection in the vector (Pal et al.,
2004). B. burgdorferi infection enhances expression of specific
tick genes such as TROSPA and salp15 that can be targeted
to prevent the transmission of Borrelia spirochetes and other
tick-borne microbes (Hovius et al., 2007). Blocking TROSPA
with TROSPA antisera or via RNA interference (RNAi) reduces
B. burgdorferi adherence to the gut of I. scapularis, and as a
result reduces bacterial colonization of the vector and, potentially,
pathogen transmission to the host (Pal et al., 2004). Bacterial
OspA has been used as a Lyme disease vaccine that blocks
pathogen transmission as anti-OspA antibodies destroy the spiro-
chetes in the tick gut before transmission to the host occurs (Pal
et al., 2000). Studies by Tsao et al. (2001) suggested that vac-
cination of mice with OspA could reduce transmission of the
bacteria to the tick vector regardless of whether the reservoir
host was previously infected or not. A combination of OspA with
TROSPA antigens may enhance vaccine protective efficacy against
Lyme disease.
Serpins (serine protease inhibitors) are a large family of struc-
turally related proteins found in a wide variety of organisms,
including hematophagous arthropods. They are known to regu-
late many important functions such as blood coagulation, food
digestion, inflammatory and immune responses (Mulenga et al.,
2001) and therefore are attractive target antigens for tick vac-
cine development. Combining different serpins to vaccinate cat-
tle results in a reduction of engorgement rates and increased
mortality of Haemaphysalis and Rhipicephalus ticks (Imamura
et al., 2005, 2006). Furthermore, immunization of cattle with a
cocktail vaccine containing recombinant R. appendiculatus ser-
pins RAS-3, RAS-4, and a 36 kDa immune-dominant protein
RIM36, reduces tick infestations and also has an effect on the
tick mortality rate of Theileria parva-infected ticks by increas-
ing it from 10.8 to 48.5% in the vaccinated group (Imamura
et al., 2008). Infection of cattle with T. parva could not be pre-
vented by the vaccine although the presence of the pathogen
in peripheral blood was delayed by a couple of days indicating
the vaccine also had an effect on pathogen transmission to the
mammalian host.
Tick Subolesin (SUB), the ortholog of insect and verte-
brate akirins (AKR) (de la Fuente et al., 2006a; Goto et al.,
2008; Canales et al., 2009c; Galindo et al., 2009; Macqueen and
Johnston, 2009; Mangold et al., 2009), was discovered as a tick
protective antigen in I. scapularis (Almazán et al., 2003). Most
vertebrates have two closely related AKR homologues, AKR1
and AKR2 (Goto et al., 2008). Only one SUB/AKR gene has
been identified in insects and ticks, which is evolutionary and
functionally related to mammalian AKR2 (de la Fuente et al.,
2006a; Goto et al., 2008; Galindo et al., 2009; Macqueen and
Johnston, 2009). SUB has a role in tick immunity and other
molecular pathways and has been shown to protect against tick
infestations and infection by vector-borne pathogen such as
A. phagocytophilum, A. marginale, B. bigemina, and B. burgdor-
feri (de la Fuente et al., 2006b; Merino et al., 2011b; Bensaci
et al., 2012). RNAi experiments have demonstrated that SUB
knockdown affects the expression of genes involved in multiple
cellular pathways (de la Fuente et al., 2006c, 2008c). It also has
an effect on pathogen infection by reducing tick innate immu-
nity that results in higher infection levels but also indirectly by
affecting tick tissue structure and function and the expression of
genes required for pathogen infection, therefore interfering with
pathogen infection and multiplication (Zivkovic et al., 2010; de
la Fuente et al., 2011) (Figure 2). Vaccines containing conserved
SUB/AKR protective epitopes have been shown to protect against
tick, mosquito and sand fly infestations, thus suggesting the pos-
sibility of developing universal vaccines for the control of arthro-
pod vector infestations (Moreno-Cid et al., 2013). However, the
effects of SUB/AKR vaccines on vector-borne viruses showed no
effect on tick-borne encephalitis virus infection and transmission
(Havlíková et al., 2013).
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FIGURE 2 | Model for Subolesin role in pathogen infection. Targeting SUB
by vaccination or RNAi reduces tick immunity, thereby increasing pathogen
infection levels. However, lower pathogen infection levels may result from the
effect on tissue structure and function and the expression of genes that are
important for pathogen infection and multiplication. Both direct and indirect
effects of targeting SUB results in lower tick infestations, feeding and fertility.
CONCLUSIONS AND FUTURE DIRECTIONS
This review has focused on studies showing the effects of tick anti-
gens on the control of tick-borne pathogens by either decreasing
the exposure of susceptible hosts to infected ticks (i.e., BM86) or
by reducing tick vector capacity (i.e., TROSPA) (Kocan, 1995; de
la Fuente and Kocan, 2003; Willadsen, 2006; de la Fuente et al.,
2007a,b).
Tick-borne pathogens are maintained in a complex enzootic
infection cycle involving ticks and vertebrate hosts (Wilson,
2002). Our understanding of the biology of vector-pathogen
interactions, primarily involving model insects has advanced
over the past decades. However, our knowledge of tick biology,
especially the molecular interactions with the pathogens they
maintain and transmit, and the mechanism by which the tick
immune response influences invading pathogens, remains insuf-
ficient. The relative fitness of a pathogen within the vector can be
a major determinant of pathogen prevalence within the vertebrate
host population. For example, strains of the tick-borne rickettsia
A. marginale differ markedly in their transmission efficiency (Ueti
et al., 2009). These areas are understudied but important and
warrant future investigation.
Transmission-blocking vaccines that interfere with specific
aspects of tick physiology important for arthropod survival or
development may prevent multiple infections that are often co-
transmitted by a single tick species, an advantage over vaccines
which only target particular pathogens. For example, immuniza-
tion of hosts using SUB significantly inhibits tick infection with
multiple pathogens such as A. marginale and B. bigemina (Merino
et al., 2011b).
Progress in the development of transmission blocking vaccines
has been slow. The limiting step in the development of vector
vaccines has been the identification of new antigens that induce
protective immune responses whilst preventing pathogen trans-
mission (de la Fuente and Kocan, 2003). The number of proteins
that may be of value as antigens has continued to increase quite
rapidly over recent years but there have not been many reports
of their actual assessment in vaccination trials (Willadsen, 2004;
Guerrero et al., 2012). Very few antigens appear to be highly
effective on their own suggesting the need for a multi-antigen
or chimeric vaccine that incorporates critical tick and pathogen
antigenic epitopes (Almazán et al., 2012; Parizi et al., 2012b;
Moreno-Cid et al., 2013) to elicit synergistic anti-pathogen and
anti-tick immune responses.
The selection of new vaccine antigens from the study of
tick-pathogen interactions using systems biology requires the
development of algorithm that allow the selection of the most
effective targets to control tick infestations and pathogen trans-
mission (de la Fuente, 2012).
Finally, identification of new protective antigens that are
conserved across vector species, with similar structure and/or
sequence motifs, may provide the opportunity to develop a uni-
versal and so more commercially viable vaccine for the control
of multiple arthropod infestations and their associated pathogens
(de la Fuente et al., 2011; Parizi et al., 2012a; Moreno-Cid et al.,
2013).
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